Living

You can read their statements, as well as an interview of the president of the American Medical Association about the bill, here.

Insurers may be allowed to not cover essential health benefits like drug costs, according to initial reports.

A man with Type 1 finds more questions than answers.

If it’s like the House’s version of the AHCA, it could mean drastic changes in health care coverage for people with diabetes.

Good advice from “Bright Spots & Landmines,” a new diabetes guide from diaTribe’s Adam Brown

The murders in two long-term care facilities took place over seven years.

Diabetes advocacy organizations warn it would hurt diabetes research and prevention programs.

Ali Dugger’s family is raising money for a wheelchair ramp as she contends with Charcot foot, a neuropathic condition that impacts the feet.

We highlight five passages where the CBO report talked about people with preexisting conditions or who were less healthy.

An insurance advocate who has a son with Type 1 diabetes argues that it would rob families of economic stability.

The mother of a Scottish teen says the school made its decision at the last minute under a false pretext.

Mick Mulvaney was part of a panel discussion where a former Democratic governor of California also characterized diabetes solely as a lifestyle disease.

Krista Ferguson joins a line of pageant contestants who were open about their Type 1 diabetes.

Mick Mulvaney, OMB director, is the latest Republican official whose rhetoric in support of the AHCA has drawn condemnation.

An around-the-world traveler with Type 1 is asked if he would have stayed home if it meant preventing Type 1 diabetes.

Sandra Speck was found guilty of involuntary manslaughter for the death of her daughter with Type 1 and other special needs.

During the trial, the Raditas were found to have improperly treated their son’s Type 1 diabetes for years.

He has signed on as a color commentator for FOX Sports

The bill has passed the House, but probably won’t survive in its current form in the Senate.

A lawsuit alleges that a diabetes educational program crossed the line into promotional marketing.